Kaplan-Meier analysis revealed significant association of higher GMF-β expression in tumor cells with shorter progression-free survival (PFS, Figure 2A, left panel) and overall survival (OS, Figure 2A, right panel) in patients of all WHO grades (P < 0.001). This evidence concerns the gene GMFB and neoplasm.